Evidence map›Paper›PMID 33062938›Full record

ArticleAccess microbiology2020

Phenotypic characterization of

Maria Cecília Gorla, Angela Pires Brandao, Juliana Maira Watanabe Pinhata, Camile de Moraes, Gabriela Pereira, Ana Paula Lemos

Open access · goldAbstract read
In one paragraph

Article in Access microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Therapeutic advances in vaccines and immunotherapy · 2020
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maria Cecília GorlaBacteriology Department, Adolfo Lutz Institute, Av. Dr. Arnaldo 351, São Paulo, CEP 01246-000, SP, Brazil.ORCID https://orcid.org/0000-0002-2657-7479
Angela Pires BrandaoBacteriology Department, Adolfo Lutz Institute, Av. Dr. Arnaldo 351, São Paulo, CEP 01246-000, SP, Brazil.ORCID https://orcid.org/0000-0002-6036-9139
Juliana Maira Watanabe PinhataBacteriology Department, Adolfo Lutz Institute, Av. Dr. Arnaldo 351, São Paulo, CEP 01246-000, SP, Brazil.
Camile de MoraesSecretariat of Health Surveillance, Ministry of Health, Esplanada dos Ministérios, Bloco G, Brasília, CEP 70058-900, DF, Brazil.ORCID https://orcid.org/0000-0003-4789-0429
Gabriela PereiraGeneral Coordination of Laboratories, Ministry of Health, Esplanada dos Ministérios, Bloco G, Brasília, CEP 70058-900, DF, Brazil.
Ana Paula LemosBacteriology Department, Adolfo Lutz Institute, Av. Dr. Arnaldo 351, São Paulo, CEP 01246-000, SP, Brazil.
Instituto Adolfo Lutz · BRMinistério da Saúde · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInvasive meningococcal disease (IMD) has a high rate of fatality and may cause severe clinical sequelae. Over the years, the epidemiology of IMD has changed significantly in various regions of the world, and laboratory surveillance of this disease is important for mapping epidemiologic changes.

aimTo perform phenotypic characterization of METHODOLOGY: In total, 8,689 isolates sent to Adolfo Lutz Institute confirmed as

resultsThe isolates were sent from all regions of Brazil, and the southeast region was responsible for the largest number of isolates (57.2 %). Overall, the total sample (

conclusionThe data show an important change in the distribution of meningococcal serogroups, serotypes and subtypes occurring during 2002-2017. A continuous laboratory-based surveillance provides robust information to implement appropriate strategies to IMD control.

Indexed as

laboratory meningococcal surveillancemeningococcal surveillanceNeisseria meningitidis

Identifiers

PMID33062938
PMCPMC7525054
OpenAlexW2996443348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.